- Filed
- Feb 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding restated | FY 2024 · Dec 31, 2023 | 50.03M sh |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $163.86M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $568.19M |
| Current Assets | FY 2024 · Dec 31, 2023 | $1B |
| Total Assets | FY 2024 · Dec 31, 2023 | $1.67B |
| Shares Diluted restated | FY 2024 · Dec 31, 2022 | 42M sh |
| Capex | FY 2024 · Dec 31, 2022 | $52.27M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$252.2M |
| Eps Diluted restated | FY 2024 · Dec 31, 2022 | −$50.20 |
| Eps Basic restated | FY 2024 · Dec 31, 2022 | −$50.15 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $1.43B |
| Rd Expense | FY 2024 · Dec 31, 2022 | $1.05B |
| Net Income | FY 2024 · Dec 31, 2022 | −$2.1B |
| Operating Income | FY 2024 · Dec 31, 2022 | −$2.21B |
| Revenue | FY 2024 · Dec 31, 2022 | $477.71M |
| Cash And Equivalents | FY 2024 · Dec 31, 2021 | $1.55B |